Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 5 In vitro elongation of nascent ribonucleic acid (run-on assay) performed in human endothelial cells exposed to following conditions: 100 µg/ml of nLDL, glycLDL, or oxLDL; glyc-oxLDL at 30, 100, and 300 µg/ml; and 100 µg/ml of the second forms of glyc-oxLDL and oxLDL. Densitometric analysis revealed a 25% reduction in NOSIII transcript after treatment with 300 µg/ml of glyc-oxLDL (*p < 0.05 vs. all other forms). Abbreviations as in Figures 2 and 3.
|
